| PDF (646kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-305280
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.30528
Zusammenfassung
The most frequent mature aggressive B-cell lymphomas are diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL). Patients suffering from molecularly defined BL (mBL) but treated with a regimen developed for DLBCL show an unfavorable outcome compared with mBL treated with chemotherapy regimens for BL. Distinguishing BL from DLBCL by conventional histopathology is challenging in lymphomas ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags